Johnson & Johnson Receives FDA Approval for New Robotic Surgical System
Johnson & Johnson received FDA approval for its Ottava Robotic surgical system, leading to a 2% rise in the stock. Meanwhile, mixed market performance was observed with tech stocks showing divergence as chip names like Nvidia rose while software and hyperscaler stocks fell due to concerns over an OpenAI security incident.
Tickers: $CRWD $IBM $JNJ $NVDA $PANW
Topics: FDA Johnson & Johnson robotic surgery